Medthrough curates and provides early‑access AI‑augmented diagnostic tools and research briefs to patients and clinicians, delivering actionable, evidence‑based recommendations that support clinical decision‑making. By validating safety and utility through independent research, the service accelerates the adoption of advanced AI technologies while keeping clinicians in supervisory control.
Funding
Funding not disclosed
Founders
Product
Problem
Patients often struggle to obtain timely, AI‑enhanced medical insights, while clinicians face growing workloads and limited tools for integrating advanced diagnostics into routine care.
Solution
Medthrough acts as an intermediary that connects patients with early‑access AI‑augmented healthcare services. The organization curates AI‑assisted physician tools, state‑of‑the‑art diagnostic algorithms, and targeted medical research findings, making them available to patients and clinicians before they become widely commercialized. By employing a team of patient advocates and researchers, Medthrough identifies the most relevant AI applications, validates their safety and utility, and facilitates their adoption in clinical workflows. The service delivers actionable insights—such as suggested questions for doctors or data‑driven diagnostic recommendations—while ensuring that all recommendations remain under clinician supervision. This approach accelerates the diffusion of beneficial AI technologies in healthcare without replacing professional medical judgment.
Target Audience
Primary users are patients seeking early access to AI‑enhanced health services and clinicians who want validated AI tools to support diagnosis and treatment planning.
Features
- Curation of vetted AI‑assisted doctor tools that augment clinical decision‑making
- Integration of cutting‑edge diagnostic algorithms for early disease detection
- Summarized, case‑relevant research briefs tailored to specific patient conditions
- Patient‑focused recommendation engine that suggests evidence‑based questions for clinicians
- Ongoing monitoring of AI tool performance and safety through independent research oversight